TechFormer OpenAI science chief launches startup with $215 million

Kevin Weil, who led OpenAI’s AI-for-science work, is starting a company that aims to use artificial intelligence to speed up a key stage of drug development.

artificial intelligencedrug developmentstartups

BBloomberg News★★☆☆☆2026-10-22 20:40Original